Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap300.72B
Enterprise Value336.62B
Trailing P/E16.47
Forward P/E15.44
MRK
(NYSE)Merck & Co., Inc.
$120.87-- (--)
Loading... - Market loading
Merck & Co. (MRK) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)4.62
Forward Price/Sales4.56
Price/Book (mrq)5.72
Price/Tangible Book (mrq)69.18
Price/FCF (ttm)24.32
Price/OCF (ttm)18.25
PEG Ratio2.48
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue5.18
EV/Earnings18.44
EV/EBITDA12.80
EV/EBIT14.58
EV/FCF27.23
Stock Price
Current price, 52-week range, and moving averages
Current Price$120.87
1-Day Change0.46%
52-Week High$125.14
52-Week Low$73.31
52-Week Change38.71%
YTD Change13.52%
1-Year Change39.54%
50-Day MA$117.05
200-Day MA$96.19
Avg Volume (30 day)6.25M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding2.49B
Book Value per Share$21.14
Net Cash per Share$4.70
FCF per Share$4.97
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$131.20
Target Upside/Downside8.55%
Analyst ConsensusBuy
Analyst Count10
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin81.50%
EBITDA Margin (ttm)40.46%
EBIT Margin (ttm)35.52%
Operating Margin (ttm)41.19%
Pretax Margin (ttm)32.41%
Profit Margin (ttm)28.08%
FCF Margin (ttm)19.01%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)34.70%
Return on Assets (ttm)13.34%
Return on Invested Capital (ttm)22.59%
Return on Capital Employed (ttm)21.27%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue65.01B
Gross Profit52.98B
Operating Income26.78B
Pretax Income21.07B
Net Income18.25B
EBITDA26.31B
EBIT23.09B
Diluted EPS$7.34
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow16.47B
Capital Expenditures4.11B
Free Cash Flow12.36B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth1.31%
Dividend Growth5.06%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)136.87B
Cash & Securities (mrq)14.56B
Net Cash (mrq)11.68B
Net Cash per Share$4.70
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)50.53B
Working Capital (mrq)15.19B
Total Equity (mrq)52.61B
Book Value per Share$21.14
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.54
Quick Ratio (mrq)1.30
Debt/Equity (mrq)0.96
Debt/EBITDA (ttm)1.92
Debt/FCF (ttm)4.09
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$3.32
Dividend Yield2.75%
Payout Ratio (Earnings)45.25%
Payout Ratio (FCF)66.83%
Dividend Growth (YoY)5.06%
Ex-Dividend DateMar 16, 2026
Pay DateApr 7, 2026
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield6.07%
FCF Yield4.11%
Buyback Yield1.69%
Total Shareholder Yield4.44%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score4.05
Piotroski F-Score4/9
Dividend Score70.12
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Lynch Fair Value$48.72
Lynch Upside/Downside-59.68%
Graham Number$59.08
Graham Upside/Downside-51.11%
Frequently Asked Questions About Merck & Co. Statistics
What are the key financial metrics for MRK?
Merck & Co., Inc. (MRK) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is MRK's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Merck & Co. is overvalued or undervalued.
How do I read MRK's profitability ratios?
Merck & Co.'s profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do MRK's debt ratios indicate?
The financial health section shows Merck & Co.'s leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is MRK's dividend analysis?
The dividend section covers Merck & Co.'s dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.